Sort by
Refine Your Search
-
60%-100%, Zurich, fixed-term We are looking for a motivated and self-organized front-end developer with expertise in data visualization and dashboards to join our dynamic team at ETH Zurich. Your
-
for world class research in the field of robotic fabrication in architecture and construction. Job description We are looking for a highly skilled software engineer to work on the development of python
-
Sciences and Technology. Job description The successful applicant will develop bioinformatics software for analysis and integration of microbiome and other omics datasets for studying microbial communities
-
will develop and implement web scraping solutions to collect data from websites, including ones with anti-bot mechanisms. This involves designing efficient scraping strategies, preprocessing collected
-
supporting those engaged in peace practice and conflict transformation processes. We are seeking someone to work as senior program officer in our “Mediation Support Project” a joint project between the CSS ETH
-
storage, and more. For more details, please see our website . Job description We are seeking a Senior Scientific Software Engineer to lead our software development efforts at the GEG. Our team develops
-
essential. Your Tasks: Development of new braze alloy formulations. Development of surface textures on diamond by laser ablation. Plan and perform experiments (DoE) in a laboratory environment. Analysis and
-
with graph-based database software. . Job description Identifying public and commercial data sources relevant to pharmaceutical production, trade, and supply chains. Writing scripts for web scraping and
-
marketing, recruiting, and administrative activities for the MAS programme. Typical marketing activities include supporting marketing campaigns, developing or revising marketing descriptions (e.g. website
-
Traumatic SCI has profound and lifelong implications for affected patients and their families. A major challenge in drug development for traumatic SCI is the high failure rate of clinical trials despite